AEON Biopharma, Inc. (AEON)

AEON Biopharma was planning to go public, but the IPO has been withdrawn.
Stock Price: $14.00 - $16.00
Current IPO price range

Total Valuation

AEON Biopharma has a market cap or net worth of $329.94 million. The enterprise value is $398.68 million.

Market Cap 329.94M
Enterprise Value 398.68M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

AEON Biopharma has 22.00 million shares outstanding.

Shares Outstanding 22.00M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 292.76
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 353.75
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of n/a, with a Debt / Equity ratio of n/a.

Current Ratio n/a
Quick Ratio 1.20
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee $187,833
Profits Per Employee -$8.90M
Employee Count 6
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
Total Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Average Volume (30 Days) n/a

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AEON Biopharma had revenue of $1.13 million and -53.41 million in losses. Earnings per share was -$2.43.

Revenue 1.13M
Gross Profit 1.13M
Operating Income -54.47M
Net Income -53.41M
EBITDA -53.41M
EBIT -53.41M
Earnings Per Share (EPS) -$2.43
Full Income Statement

Balance Sheet

The company has $10.61 million in cash and $79.34 million in debt, giving a net cash position of -$68.74 million or -$3.12 per share.

Cash & Cash Equivalents 10.61M
Total Debt 79.34M
Net Cash -68.74M
Net Cash Per Share -$3.12
Book Value -207.66M
Book Value Per Share -9.44
Working Capital 8.62M
Full Balance Sheet

Cash Flow

Operating Cash Flow -19.96M
Capital Expenditures n/a
Free Cash Flow -19.96M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -4,833.01% and -4,738.86%.

Gross Margin 100.00%
Operating Margin -4,833.01%
Pretax Margin n/a
Profit Margin -4,738.86%
EBITDA Margin -4,738.78%
EBIT Margin -4,738.78%
FCF Margin -1,770.81%

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -16.19%
FCF Yield -6.05%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a